An estimated 57.4 million people live with dementia worldwide, (1) and unfortunately, clinical trials for dementia treatments have resulted in few pharmacotherapies – none of them curative. (2) (3) (4) For World Alzheimer’s Day, Prime Patient explore how Pharma can collaborate with people living with dementia to optimise the industry’s dementia research and patient community support.
Prime Global Buzz.
News and views from our business and beyond
Pick a category
Have hybrid congresses reached their full potential in providing a true omnichannel experience? Michelle Collins, Head of Digital Solutions at Prime Global, discusses.
The working day accounts for a lot of our time. On average, over a third of people’s days are spent at work. Because of this, it is extremely important we ensure we are spending this time in a place that is enjoyable and rewarding to work at.read more >>
We are delighted to have been featured in MM+M’s article, A medical marketing blind spot: LGBTQIA+ communities being left behind.read more >>
Many agree that disability inclusion in clinical trials is a worthy pursuit, but the historical significance and future impact of pursuing this goal is relatively unexplored. Here, we peel back the layers of this vital mission.
At Prime Global, we are committed to supporting charities and causes that have a direct impact on our communities. This year, we organised the Prime Global Walking Challenge, a virtual walking challenge as part of our ESG initiative to help raise money for the Rainforest Action Network.read more >>
We take a look at the value of patient data, how it can impact Pharma and to what extent it could benefit the industry.
We caught up with Senior Health Economist Idaira Rodriguez Santana, to find out more about her role as well as her biggest achievements so far!read more >>
For Pride Month 2022, Prime Patient investigate how Pharma can build stronger, more productive relationships with the LGBTQIA+ community
This Pride Month, Prime Patient takes a close look at the health inequity faced by the transgender community, and what we can do about it.